Insertable cardiac monitor, designed to reduce data burden and improve accurate diagnosis of difficult-to-detect abnormal heart rhythms

Aug. 3, 2021

Abbott announced the U.S. launch of Jot Dx, the company’s latest insertable cardiac monitor (ICM). The Jot Dx ICM gives clinicians and hospitals control of how they manage the flow of information through a unique feature to view either all abnormal heart rhythm data or to simplify which irregular heart rhythms are recorded with a "key episodes" option.

This technology allows for remote detection and improved diagnosis accuracy of cardiac arrythmia in patients. The monitor is supported by SyncUP, a personalized service that delivers one-on-one training and education to help patients get connected and stay connected to their ICM.

To better help physicians diagnose their patients’ abnormal heart rhythms, Jot Dx ICM continuously monitors patient cardiac rhythms 24 hours a day, 7 days a week and connects directly to myMerlin, a downloadable mobile app that transmits data in real-time to both the clinician and patient.

Jot provides clinicians increased control over patient monitoring, with an option to toggle between viewing only three key episodes or all episodes depending on individual patient needs to make and accurate diagnosis. This functionality reduces overall data burden. For example, for every 100 patients, it can save clinic staff up to 120 hours per month in reviewing electromyogram (EGM) transmissions while also providing the flexibility needed to find hard-to-detect arrhythmias.

Abbott is also improving how patients interact with their device. A key element in the setup is the new SyncUP support service, which Abbott offers on select products as part of its connected care portfolio. With the platform, an Abbott support expert will enroll a patient with a newly implanted device in the system, orient them through getting to know their new heart monitoring device and confirm connection to the myMerlin app.

Once connected, clinicians can monitor patients remotely, allowing for identification of asymptomatic episodes, as well as patient-triggered transmissions, which can lead to earlier intervention. Remote monitoring can shorten the time for doctors to diagnosis and make a care decision, if needed.

Abbott release